Multiple Sclerosis Trial, Recruiting NCT06554340 Sponsor: University of Massachusetts, Boston Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06554340
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been officially diagnosed with multiple sclerosis, with a disability level that falls in a moderate range (EDSS score between 4 and 6.5)
  • You have higher-than-normal blood pressure, meaning your systolic (top number) is above 120 mmHg or your diastolic (bottom number) is above 80 mmHg
  • You currently do less than 60 minutes of physical activity per week
  • Your body mass index (a measure of body weight relative to height) is below 40
  • You are able to walk and are not fully dependent on a wheelchair
  • You have had a multiple sclerosis relapse (a flare-up of symptoms) within the past 30 days
  • Your current medications have been stable and unchanged (confirm with trial site)

Who may not be able to join:

  • You have additional heart or blood vessel conditions beyond high blood pressure
  • You have Type 1 diabetes
  • Your doctor has advised against you taking part in the study
  • There is not enough space in your home to fit an exercise bike (cycle ergometer)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bo Fernhall, PhD, University of Massachusetts, Boston

Phone: 2178404493

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Massachusetts, Boston
Registry
ClinicalTrials.gov
Start date
15 April 2025
Est. completion
1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Information processing speed; Timed 25-Foot Walk

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov